Qiagen NV | QIA - Ebit

Stock Price
34.29
Daily Change
-1.02 -2.89%
Monthly
-7.74%
Yearly
-7.24%
Q2 Forecast
34.40

Qiagen NV reported $121.88M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
argenx SE USD 371.14M 21.17M Dec/2025
Avita Medical AUD -10.39M 1.72M Dec/2025
Dianthus Therapeutics USD -69.54M 29.25M Dec/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Moderna USD -857M 597M Dec/2025
Organon & Co USD 388M 28M Sep/2025
Qiagen NV USD 121.88M 19.18M Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
Tectonic Therapeutic USD -21.52M 374K Dec/2025
Viatris USD -157.5M 392M Dec/2025
Xeris Pharmaceuticals USD 16.77M 8.88M Dec/2025